Hsinchu, Taiwan

Hsien-Chih Lai

This inventor holds 1 USPTO granted patent. Top assignee: National Tsing Hua University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hsien-Chih Lai. Retrieved from https://idiyas.com/inventor/hsien-chih-lai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hsien-Chih Lai: Innovator in Influenza Detection

Introduction

Hsien-Chih Lai is a prominent inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of influenza viruses. His innovative work has led to the development of a specific aptamer for the Influenza A H1N1 subtype.

Latest Patents

Hsien-Chih Lai holds a patent for an "Influenza A H1N1 subtype-specific aptamer and applications thereof." This invention provides a stable aptamer that was selected in vitro using SELEX and a microfluidic chip system. The aptamer demonstrates sensitivity approximately 100 times higher than traditional antibodies and exhibits high specificity to the Influenza A H1N1 subtype. This advancement is crucial for effective detection of the H1N1 influenza virus.

Career Highlights

Hsien-Chih Lai is affiliated with National Tsing Hua University, where he continues to engage in research and development. His work has garnered attention for its potential impact on public health and disease management.

Collaborations

He has collaborated with notable colleagues, including Tong-Minn Liou and Gwo-Bin Lee, to further enhance the research and application of his inventions.

Conclusion

Hsien-Chih Lai's contributions to influenza detection through innovative aptamer technology highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also has practical implications for improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…